ムピロシン軟膏の世界市場レポート2026-2032

QY Research > レポート一覧 > 薬品及びサプリメント > ムピロシン軟膏の世界市場レポート2026-2032

英文タイトル： Global Mupirocin Ointment Market Research Report 2026

レポートID：1639604
発表時期：2026-01-05
訪問回数：496
ページ数：123
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：120
レポートカテゴリ：薬品及びサプリメント

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

世界のムピロシン軟膏市場は、2025年に493百万米ドルと算定されており、2026年には507百万米ドルとなる見通しです。2026年から2032年の期間においては年平均成長率（CAGR）3.2%で推移し、2032年には612百万米ドルに達すると予測されています。

本レポートは、ムピロシン軟膏メーカー、新規参入企業、および業界バリューチェーン全体の企業に対し、市場全体およびサブセグメント別の収益、生産量、平均価格に関する情報を、企業別、タイプ別、用途別、地域別に提供します。
世界のムピロシン軟膏市場について、定量的・定性的分析を交えた包括的な概観を提供し、企業関係者が成長戦略の策定、競争環境の評価、現行市場における自社の位置付けの分析、ムピロシン軟膏に関する情報に基づいたビジネス判断を行うことを支援します。ムピロシン軟膏市場の規模、推定値及び予測値の観点から提示し、2025年を基準年として、2021年から2032年までの過去データ及び予測データを収録しております。

報告対象範囲
売上高・数量予測、企業シェア、競争環境、成長要因および市場トレンド

市場セグメンテーション
企業一覧
Glenmark Pharms
Glaxosmithkline
SmithKline & French
Humanwell Healthcare
Taro Pharmaceutical
Teva
Perrigo
Hanzhou Zhuyangxin Pharmaceutical
GSK
Sun Pharmaceutical
Bausch Health

タイプ別
Below 10g
10g-20g
Above 20g

用途別
Hospital
Retail Pharmacy
Others

製品カテゴリー

市場セグメント

地域別
北米（アメリカ、カナダ、メキシコ）
欧州（ドイツ、フランス、イギリス、イタリアなど）
アジア太平洋（中国、日本、韓国、東南アジア、インドなど）
南米（ブラジルなど）
中東・アフリカ（トルコ、GCC諸国、アフリカなど）
本レポートは、世界のムピロシン軟膏市場を包括的にセグメント化しております。地域別市場規模、タイプ別、用途別、企業別の市場規模も提供されます。より深い洞察を得るため、競争環境、主要競合他社、それぞれの市場順位をプロファイリングし、技術動向や新製品開発についても論じております。

本レポートの構成
第1章：ムピロシン軟膏の定義および調査範囲を明確化し、市場セグメント（タイプ別、用途別など）の概要を提示します。各セグメントの市場規模と将来の成長可能性を網羅し、現在の市場状況の概要を提供するとともに、短期・中期・長期の発展トレンドを分析します
第2章：ムピロシン軟膏メーカーの競争環境について、価格、生産量、価値ベースの市場シェア、最新の開発計画、合併・買収情報を含め詳細に分析します
第3章：ムピロシン軟膏の生産量／生産高および価値を地域・国別に検証し、今後6年間の各地域の市場規模と成長可能性について定量的な評価を提供します
第4章：地域および国レベルでのムピロシン軟膏の消費動向を分析します。各地域および主要国における市場規模と成長可能性を定量化し、市場開発状況、見通し、対応可能な市場規模、国内生産量を概説します
第5章：ムピロシン軟膏に基づくタイプ別市場セグメントの構造を整理し、各セグメントの市場規模と成長ポテンシャルを明確化することで、企業・投資家によるブルーオーシャン機会の発見を支援します
第6章：用途別にムピロシン軟膏の市場セグメントを整理し、各分野の市場規模、成長ポテンシャル、需要拡大余地を提示することで、下流市場における有望な参入機会や競争優位の確立に向けた判断材料を提供します
第7章：ムピロシン軟膏の主要プレイヤーを分析し、主要企業の基本情報（製品生産量／生産高、価値、価格、粗利益率、製品ポートフォリオ／新製品導入、最近の動向）を詳細に説明します
第8章：ムピロシン軟膏の上流および下流セグメントを含む業界バリューチェーンをレビューします
第9章：ムピロシン軟膏市場の動向と最新トレンドについて議論します。これには、メーカーにとっての推進要因、制約要因、課題、リスク、米国関税、関連政策分析が含まれます
第10章：主な調査結果と結論をまとめます
第11章：付録

Description

The global Mupirocin Ointment market was valued at US$ 493 million in 2025 and is anticipated to reach US$ 612 million by 2032, at a CAGR of 3.2% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Mupirocin Ointment competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.

The mupirocin ointment market is driven by the increasing prevalence of skin infections, including impetigo, as well as the rising incidence of antibiotic-resistant bacterial strains like MRSA (methicillin-resistant Staphylococcus aureus). Mupirocin ointment is widely used as a topical antibiotic for treating various bacterial skin infections, making it an essential product in both hospitals and community healthcare settings. The growing awareness of effective wound care, along with increased healthcare access in developing regions, is also contributing to the demand for mupirocin ointment.

A key challenge in the mupirocin ointment market is the potential for bacterial resistance due to the overuse or misuse of antibiotics, which can reduce the long-term efficacy of the product. Additionally, competition from alternative topical antibiotics and newer antimicrobial therapies could limit market growth. Pricing pressures, particularly in regions with generic product availability, may also impact market share and profitability for branded formulations. Furthermore, stringent regulatory requirements for manufacturing and product approval add to the complexity of market entry for new players.

Currently, global production of Mupirocin Ointment is concentrated as there are few manufacturers engaged in the industry. The largest manufacturer is Glenmark Pharms, who owns 37% revenue market share. As for the region, North America is the largest consumption region, holding 35% revenue market share, followed by China, with 22% market share. Mupirocin Ointment is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria. Among various applications, demand from Retail Pharmacy is the largest sold channel.

This report delivers a comprehensive overview of the global Mupirocin Ointment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mupirocin Ointment. The Mupirocin Ointment market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Mupirocin Ointment market comprehensively. Regional market sizes by Type, by Sales Channel, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mupirocin Ointment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Sales Channel, and by region.

Market Segmentation
By Company
Glenmark Pharms
Glaxosmithkline
SmithKline & French
Humanwell Healthcare
Taro Pharmaceutical
Teva
Perrigo
Hanzhou Zhuyangxin Pharmaceutical
GSK
Sun Pharmaceutical
Bausch Health

Segment by Type
Below 10g
10g-20g
Above 20g

by Sales Channel
Hospital
Retail Pharmacy
Others

Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Sales Channel, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Mupirocin Ointment manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Mupirocin Ointment sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Sales Channel, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

Table of Contents

1 Mupirocin Ointment Market Overview
1.1 Product Definition
1.2 Mupirocin Ointment by Type
1.2.1 Global Mupirocin Ointment Market Value by Type: 2025 vs 2032
1.2.2 Below 10g
1.2.3 10g-20g
1.2.4 Above 20g
1.3 Mupirocin Ointment by Sales Channel
1.3.1 Global Mupirocin Ointment Market Value by Sales Channel: 2025 vs 2032
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Mupirocin Ointment Market Size Estimates and Forecasts
1.4.1 Global Mupirocin Ointment Revenue 2021–2032
1.4.2 Global Mupirocin Ointment Sales 2021–2032
1.4.3 Global Mupirocin Ointment Market Average Price (2021–2032)
1.5 Assumptions and Limitations

2 Mupirocin Ointment Market Competition by Manufacturers
2.1 Global Mupirocin Ointment Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mupirocin Ointment Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mupirocin Ointment Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mupirocin Ointment, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mupirocin Ointment, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mupirocin Ointment, Product Types and Applications
2.7 Global Key Manufacturers of Mupirocin Ointment, Date of Entry into the Industry
2.8 Global Mupirocin Ointment Market Competitive Situation and Trends
2.8.1 Global Mupirocin Ointment Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mupirocin Ointment Players Market Share by Revenue
2.8.3 Global Mupirocin Ointment Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Mupirocin Ointment Market Scenario by Region
3.1 Global Mupirocin Ointment Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mupirocin Ointment Sales by Region: 2021–2032
3.2.1 Global Mupirocin Ointment Sales by Region: 2021–2026
3.2.2 Global Mupirocin Ointment Sales by Region: 2027–2032
3.3 Global Mupirocin Ointment Revenue by Region: 2021–2032
3.3.1 Global Mupirocin Ointment Revenue by Region: 2021–2026
3.3.2 Global Mupirocin Ointment Revenue by Region: 2027–2032
3.4 North America Mupirocin Ointment Market Facts & Figures by Country
3.4.1 North America Mupirocin Ointment Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mupirocin Ointment Sales by Country (2021–2032)
3.4.3 North America Mupirocin Ointment Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mupirocin Ointment Market Facts & Figures by Country
3.5.1 Europe Mupirocin Ointment Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mupirocin Ointment Sales by Country (2021–2032)
3.5.3 Europe Mupirocin Ointment Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mupirocin Ointment Market Facts & Figures by Region
3.6.1 Asia Pacific Mupirocin Ointment Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mupirocin Ointment Sales by Region (2021–2032)
3.6.3 Asia Pacific Mupirocin Ointment Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mupirocin Ointment Market Facts & Figures by Country
3.7.1 Latin America Mupirocin Ointment Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mupirocin Ointment Sales by Country (2021–2032)
3.7.3 Latin America Mupirocin Ointment Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mupirocin Ointment Market Facts & Figures by Country
3.8.1 Middle East and Africa Mupirocin Ointment Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mupirocin Ointment Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mupirocin Ointment Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE

4 Segment by Type
4.1 Global Mupirocin Ointment Sales by Type (2021–2032)
4.1.1 Global Mupirocin Ointment Sales by Type (2021–2026)
4.1.2 Global Mupirocin Ointment Sales by Type (2027–2032)
4.1.3 Global Mupirocin Ointment Sales Market Share by Type (2021–2032)
4.2 Global Mupirocin Ointment Revenue by Type (2021–2032)
4.2.1 Global Mupirocin Ointment Revenue by Type (2021–2026)
4.2.2 Global Mupirocin Ointment Revenue by Type (2027–2032)
4.2.3 Global Mupirocin Ointment Revenue Market Share by Type (2021–2032)
4.3 Global Mupirocin Ointment Price by Type (2021–2032)

5 Segment by Sales Channel
5.1 Global Mupirocin Ointment Sales by Sales Channel (2021–2032)
5.1.1 Global Mupirocin Ointment Sales by Sales Channel (2021–2026)
5.1.2 Global Mupirocin Ointment Sales by Sales Channel (2027–2032)
5.1.3 Global Mupirocin Ointment Sales Market Share by Sales Channel (2021–2032)
5.2 Global Mupirocin Ointment Revenue by Sales Channel (2021–2032)
5.2.1 Global Mupirocin Ointment Revenue by Sales Channel (2021–2026)
5.2.2 Global Mupirocin Ointment Revenue by Sales Channel (2027–2032)
5.2.3 Global Mupirocin Ointment Revenue Market Share by Sales Channel (2021–2032)
5.3 Global Mupirocin Ointment Price by Sales Channel (2021–2032)

6 Key Companies Profiled
6.1 Glenmark Pharms
6.1.1 Glenmark Pharms Company Information
6.1.2 Glenmark Pharms Description and Business Overview
6.1.3 Glenmark Pharms Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Glenmark Pharms Mupirocin Ointment Product Portfolio
6.1.5 Glenmark Pharms Recent Developments/Updates
6.2 Glaxosmithkline
6.2.1 Glaxosmithkline Company Information
6.2.2 Glaxosmithkline Description and Business Overview
6.2.3 Glaxosmithkline Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Glaxosmithkline Mupirocin Ointment Product Portfolio
6.2.5 Glaxosmithkline Recent Developments/Updates
6.3 SmithKline & French
6.3.1 SmithKline & French Company Information
6.3.2 SmithKline & French Description and Business Overview
6.3.3 SmithKline & French Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 SmithKline & French Mupirocin Ointment Product Portfolio
6.3.5 SmithKline & French Recent Developments/Updates
6.4 Humanwell Healthcare
6.4.1 Humanwell Healthcare Company Information
6.4.2 Humanwell Healthcare Description and Business Overview
6.4.3 Humanwell Healthcare Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Humanwell Healthcare Mupirocin Ointment Product Portfolio
6.4.5 Humanwell Healthcare Recent Developments/Updates
6.5 Taro Pharmaceutical
6.5.1 Taro Pharmaceutical Company Information
6.5.2 Taro Pharmaceutical Description and Business Overview
6.5.3 Taro Pharmaceutical Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Taro Pharmaceutical Mupirocin Ointment Product Portfolio
6.5.5 Taro Pharmaceutical Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Teva Mupirocin Ointment Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Perrigo
6.7.1 Perrigo Company Information
6.7.2 Perrigo Description and Business Overview
6.7.3 Perrigo Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Perrigo Mupirocin Ointment Product Portfolio
6.7.5 Perrigo Recent Developments/Updates
6.8 Hanzhou Zhuyangxin Pharmaceutical
6.8.1 Hanzhou Zhuyangxin Pharmaceutical Company Information
6.8.2 Hanzhou Zhuyangxin Pharmaceutical Description and Business Overview
6.8.3 Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Product Portfolio
6.8.5 Hanzhou Zhuyangxin Pharmaceutical Recent Developments/Updates
6.9 GSK
6.9.1 GSK Company Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 GSK Mupirocin Ointment Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Sun Pharmaceutical
6.10.1 Sun Pharmaceutical Company Information
6.10.2 Sun Pharmaceutical Description and Business Overview
6.10.3 Sun Pharmaceutical Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Sun Pharmaceutical Mupirocin Ointment Product Portfolio
6.10.5 Sun Pharmaceutical Recent Developments/Updates
6.11 Bausch Health
6.11.1 Bausch Health Company Information
6.11.2 Bausch Health Description and Business Overview
6.11.3 Bausch Health Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Bausch Health Mupirocin Ointment Product Portfolio
6.11.5 Bausch Health Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis
7.1 Mupirocin Ointment Industry Chain Analysis
7.2 Mupirocin Ointment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mupirocin Ointment Production Mode & Process Analysis
7.4 Mupirocin Ointment Sales and Marketing
7.4.1 Mupirocin Ointment Sales Channels
7.4.2 Mupirocin Ointment Distributors
7.5 Mupirocin Ointment Customer Analysis

8 Mupirocin Ointment Market Dynamics
8.1 Mupirocin Ointment Industry Trends
8.2 Mupirocin Ointment Market Drivers
8.3 Mupirocin Ointment Market Challenges
8.4 Mupirocin Ointment Market Restraints
8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Mupirocin Ointment Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Mupirocin Ointment Market Value by Sales Channel (US$ Million), 2025 vs 2032
 Table 3. Global Mupirocin Ointment Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Mupirocin Ointment Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Mupirocin Ointment Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Mupirocin Ointment Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Mupirocin Ointment Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Mupirocin Ointment Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Mupirocin Ointment, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Mupirocin Ointment, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Mupirocin Ointment, Product Types and Applications
 Table 12. Global Key Manufacturers of Mupirocin Ointment, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mupirocin Ointment Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mupirocin Ointment Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mupirocin Ointment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Mupirocin Ointment Sales by Region (K Units), 2021–2026
 Table 18. Global Mupirocin Ointment Sales Market Share by Region (2021–2026)
 Table 19. Global Mupirocin Ointment Sales by Region (K Units), 2027–2032
 Table 20. Global Mupirocin Ointment Sales Market Share by Region (2027–2032)
 Table 21. Global Mupirocin Ointment Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Mupirocin Ointment Revenue Market Share by Region (2021–2026)
 Table 23. Global Mupirocin Ointment Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Mupirocin Ointment Revenue Market Share by Region (2027–2032)
 Table 25. North America Mupirocin Ointment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Mupirocin Ointment Sales by Country (K Units), 2021–2026
 Table 27. North America Mupirocin Ointment Sales by Country (K Units), 2027–2032
 Table 28. North America Mupirocin Ointment Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Mupirocin Ointment Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Mupirocin Ointment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Mupirocin Ointment Sales by Country (K Units), 2021–2026
 Table 32. Europe Mupirocin Ointment Sales by Country (K Units), 2027–2032
 Table 33. Europe Mupirocin Ointment Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Mupirocin Ointment Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Mupirocin Ointment Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Mupirocin Ointment Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Mupirocin Ointment Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Mupirocin Ointment Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Mupirocin Ointment Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Mupirocin Ointment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Mupirocin Ointment Sales by Country (K Units), 2021–2026
 Table 42. Latin America Mupirocin Ointment Sales by Country (K Units), 2027–2032
 Table 43. Latin America Mupirocin Ointment Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Mupirocin Ointment Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Mupirocin Ointment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Mupirocin Ointment Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Mupirocin Ointment Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Mupirocin Ointment Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Mupirocin Ointment Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Mupirocin Ointment Sales (K Units) by Type (2021–2026)
 Table 51. Global Mupirocin Ointment Sales (K Units) by Type (2027–2032)
 Table 52. Global Mupirocin Ointment Sales Market Share by Type (2021–2026)
 Table 53. Global Mupirocin Ointment Sales Market Share by Type (2027–2032)
 Table 54. Global Mupirocin Ointment Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Mupirocin Ointment Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Mupirocin Ointment Revenue Market Share by Type (2021–2026)
 Table 57. Global Mupirocin Ointment Revenue Market Share by Type (2027–2032)
 Table 58. Global Mupirocin Ointment Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Mupirocin Ointment Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Mupirocin Ointment Sales (K Units) by Sales Channel (2021–2026)
 Table 61. Global Mupirocin Ointment Sales (K Units) by Sales Channel (2027–2032)
 Table 62. Global Mupirocin Ointment Sales Market Share by Sales Channel (2021–2026)
 Table 63. Global Mupirocin Ointment Sales Market Share by Sales Channel (2027–2032)
 Table 64. Global Mupirocin Ointment Revenue (US$ Million) by Sales Channel (2021–2026)
 Table 65. Global Mupirocin Ointment Revenue (US$ Million) by Sales Channel (2027–2032)
 Table 66. Global Mupirocin Ointment Revenue Market Share by Sales Channel (2021–2026)
 Table 67. Global Mupirocin Ointment Revenue Market Share by Sales Channel (2027–2032)
 Table 68. Global Mupirocin Ointment Price (US$/Unit) by Sales Channel (2021–2026)
 Table 69. Global Mupirocin Ointment Price (US$/Unit) by Sales Channel (2027–2032)
 Table 70. Glenmark Pharms Company Information
 Table 71. Glenmark Pharms Description and Business Overview
 Table 72. Glenmark Pharms Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Glenmark Pharms Mupirocin Ointment Product
 Table 74. Glenmark Pharms Recent Developments/Updates
 Table 75. Glaxosmithkline Company Information
 Table 76. Glaxosmithkline Description and Business Overview
 Table 77. Glaxosmithkline Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Glaxosmithkline Mupirocin Ointment Product
 Table 79. Glaxosmithkline Recent Developments/Updates
 Table 80. SmithKline & French Company Information
 Table 81. SmithKline & French Description and Business Overview
 Table 82. SmithKline & French Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. SmithKline & French Mupirocin Ointment Product
 Table 84. SmithKline & French Recent Developments/Updates
 Table 85. Humanwell Healthcare Company Information
 Table 86. Humanwell Healthcare Description and Business Overview
 Table 87. Humanwell Healthcare Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Humanwell Healthcare Mupirocin Ointment Product
 Table 89. Humanwell Healthcare Recent Developments/Updates
 Table 90. Taro Pharmaceutical Company Information
 Table 91. Taro Pharmaceutical Description and Business Overview
 Table 92. Taro Pharmaceutical Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Taro Pharmaceutical Mupirocin Ointment Product
 Table 94. Taro Pharmaceutical Recent Developments/Updates
 Table 95. Teva Company Information
 Table 96. Teva Description and Business Overview
 Table 97. Teva Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Teva Mupirocin Ointment Product
 Table 99. Teva Recent Developments/Updates
 Table 100. Perrigo Company Information
 Table 101. Perrigo Description and Business Overview
 Table 102. Perrigo Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Perrigo Mupirocin Ointment Product
 Table 104. Perrigo Recent Developments/Updates
 Table 105. Hanzhou Zhuyangxin Pharmaceutical Company Information
 Table 106. Hanzhou Zhuyangxin Pharmaceutical Description and Business Overview
 Table 107. Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Product
 Table 109. Hanzhou Zhuyangxin Pharmaceutical Recent Developments/Updates
 Table 110. GSK Company Information
 Table 111. GSK Description and Business Overview
 Table 112. GSK Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. GSK Mupirocin Ointment Product
 Table 114. GSK Recent Developments/Updates
 Table 115. Sun Pharmaceutical Company Information
 Table 116. Sun Pharmaceutical Description and Business Overview
 Table 117. Sun Pharmaceutical Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Sun Pharmaceutical Mupirocin Ointment Product
 Table 119. Sun Pharmaceutical Recent Developments/Updates
 Table 120. Bausch Health Company Information
 Table 121. Bausch Health Description and Business Overview
 Table 122. Bausch Health Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Bausch Health Mupirocin Ointment Product
 Table 124. Bausch Health Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Mupirocin Ointment Distributors List
 Table 128. Mupirocin Ointment Customers List
 Table 129. Mupirocin Ointment Market Trends
 Table 130. Mupirocin Ointment Market Drivers
 Table 131. Mupirocin Ointment Market Challenges
 Table 132. Mupirocin Ointment Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mupirocin Ointment
 Figure 2. Global Mupirocin Ointment Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Mupirocin Ointment Market Share by Type: 2025 & 2032
 Figure 4. Below 10g Product Picture
 Figure 5. 10g-20g Product Picture
 Figure 6. Above 20g Product Picture
 Figure 7. Global Mupirocin Ointment Market Value by Sales Channel (US$ Million), 2021–2032
 Figure 8. Global Mupirocin Ointment Market Share by Sales Channel: 2025 & 2032
 Figure 9. Hospital
 Figure 10. Retail Pharmacy
 Figure 11. Others
 Figure 12. Global Mupirocin Ointment Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Mupirocin Ointment Market Size (US$ Million), 2021–2032
 Figure 14. Global Mupirocin Ointment Sales (K Units), 2021–2032
 Figure 15. Global Mupirocin Ointment Average Price (US$/Unit), 2021–2032
 Figure 16. Mupirocin Ointment Report Years Considered
 Figure 17. Mupirocin Ointment Sales Share by Manufacturers in 2025
 Figure 18. Global Mupirocin Ointment Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Mupirocin Ointment Players: Market Share by Revenue in Mupirocin Ointment in 2025
 Figure 20. Mupirocin Ointment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Mupirocin Ointment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Mupirocin Ointment Sales Market Share by Country (2021–2032)
 Figure 23. North America Mupirocin Ointment Revenue Market Share by Country (2021–2032)
 Figure 24. United States Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Mupirocin Ointment Sales Market Share by Country (2021–2032)
 Figure 27. Europe Mupirocin Ointment Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Mupirocin Ointment Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Mupirocin Ointment Revenue Market Share by Region (2021–2032)
 Figure 35. China Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Mupirocin Ointment Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Mupirocin Ointment Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Mupirocin Ointment Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Mupirocin Ointment Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Mupirocin Ointment by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Mupirocin Ointment by Type (2021–2032)
 Figure 56. Global Mupirocin Ointment Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Mupirocin Ointment by Sales Channel (2021–2032)
 Figure 58. Global Revenue Market Share of Mupirocin Ointment by Sales Channel (2021–2032)
 Figure 59. Global Mupirocin Ointment Price (US$/Unit) by Sales Channel (2021–2032)
 Figure 60. Mupirocin Ointment Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed

以下、関連資料のご紹介